Clinical impact of tumour biology in the management of gastroesophageal cancer

由 Lordick, Florian, Janjigian, Yelena Y.
發表在 Nat Rev Clin Oncol (2016)

The genomics and therapeutics of HER2-positive gastric cancer—from trastuzumab and beyond

由 Kelly, Ciara M., Janjigian, Yelena Y.
發表在 J Gastrointest Oncol (2016)

Targeting EGFR in Esophagogastric Cancer

由 Maron, Steven B., Xu, James, Janjigian, Yelena Y.
發表在 Front Oncol (2020)

Checkpoint Blockade in Esophagogastric Cancer

由 Cohen, Noah A., Strong, Vivian E., Janjigian, Yelena Y.
發表在 J Surg Oncol (2018)

Molecular Classification of Gastric Cancer: A new paradigm

由 Shah, Manish A., Khanin, Raya, Tang, Laura, Janjigian, Yelena Y., Klimstra, David S., Gerdes, Hans, Kelsen, David P.
出版 2011

Unique considerations for females undergoing esophagectomy

由 Nobel, Tamar B, Livschitz, Jennifer, Eljalby, Mahmoud, Janjigian, Yelena Y, Bains, Manjit S, Adusumilli, Prasad S, Jones, David R, Molena, Daniela
發表在 Ann Surg (2020)

Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma

由 Chhabra, Arpit, Ong, Leonard T, Kuk, Deborah, Ku, Geoffrey, Ilson, David, Janjigian, Yelena Y, Wu, Abraham, Schöder, Heiko, Goodman, Karyn A
發表在 Br J Cancer (2015)

Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer

由 Sihag, Smita, Ku, Geoffrey Y., Tan, Kay See, Nussenzweig, Samuel, Wu, Abraham, Janjigian, Yelena Y., Jones, David R., Molena, Daniela
發表在 J Thorac Cardiovasc Surg (2020)

Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors

由 Pereira, Patrícia M.R., Mandleywala, Komal, Ragupathi, Ashwin, Carter, Lukas M., Goos, Jeroen A.C.M., Janjigian, Yelena Y., Lewis, Jason S.
發表在 J Nucl Med (2019)

Pack Years of Cigarette Smoking as a Prognostic Factor in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer

由 Janjigian, Yelena Y., McDonnell, Kevin, Kris, Mark G., Shen, Ronglai, Sima, Camelia S., Bach, Peter B., Rizvi, Naiyer A., Riely, Gregory J.
出版 2010

CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance

由 Yoon, Changhwan, Park, Do Joong, Schmidt, Benjamin, Thomas, Nicholas J., Lee, Hae-June, Kim, Teresa S., Janjigian, Yelena Y., Cohen, Deirdre J., Yoon, Sam S.
出版 2014

Risk factors for Recurrence in T1-2N0 Gastric Cancer in the United States and China

由 Cao, Liang, Selby, Luke V., Hu, Xiang, Zhang, Yi, Janjigian, Yelena Y., Tang, Laura, Coit, Daniel G., Brennan, Murray F., Strong, Vivian E.
發表在 J Surg Oncol (2016)

A Comparison of Long and Short-term Outcomes in 845 Open and Minimally Invasive Gastrectomies for Gastric Cancer in the United States

由 Nakauchi, Masaya, Vos, Elvira, Janjigian, Yelena Y., Ku, Geoffrey Y., Schattner, Mark A., Nishimura, Makoto, Gonen, Mithat, Coit, Daniel G., Strong, Vivian E.
發表在 Ann Surg Oncol (2021)

MET expression and amplification in patients with localized gastric cancer

由 Janjigian, Yelena Y., Tang, Laura H., Coit, Daniel G., Kelsen, David P., Francone, Todd D., Weiser, Martin R., Jhanwar, Suresh C., Shah, Manish A.
出版 2011

Morbidity after Total Gastrectomy: Analysis of 238 Patients

由 Selby, Luke V., Vertosick, Emily A., Sjoberg, Daniel D., Schattner, Mark A., Janjigian, Yelena Y., Brennan, Murray F., Coit, Daniel G., Strong, Vivian E.
發表在 J Am Coll Surg (2015)

A Phase I Trial of SJG-136 (NSC#694501) in Advanced Solid Tumors

由 Janjigian, Yelena Y, Lee, Wooin, Kris, Mark G, Miller, Vincent A, Krug, Lee M, Azzoli, Christopher G, Senturk, Emir, Calcutt, M.Wade, Rizvi, Naiyer A
出版 2009

Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy

由 Pereira, Patrícia M. R., Sharma, Sai Kiran, Carter, Lukas M., Edwards, Kimberly J., Pourat, Jacob, Ragupathi, Ashwin, Janjigian, Yelena Y., Durack, Jeremy C., Lewis, Jason S.
發表在 Nat Commun (2018)

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations

由 Janjigian, Yelena Y., Park, Bernard J., Zakowski, Maureen F., Ladanyi, Marc, Pao, William, D’Angelo, Sandra P., Kris, Mark G., Shen, Ronglai, Zheng, Junting, Azzoli, Christopher G.
出版 2011

Efficacy and Safety of Bevacizumab in Active Brain Metastases from Non-Small Cell Lung Cancer

由 De Braganca, Kevin C., Janjigian, Yelena Y., Azzoli, Christopher G., Kris, Mark G., Pietanza, Maria C., Nolan, Craig P., Omuro, Antonio M., Holodny, Andrei I., Lassman, Andrew B.
出版 2010

Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer

由 Janjigian, Yelena Y., Vakiani, Efsevia, Ku, Geoffrey Y., Herrera, Jessica M., Tang, Laura H., Bouvier, Nancy, Viale, Agnès, Socci, Nicholas D., Capanu, Marinela, Berger, Michael, Ilson, David H.
發表在 PLoS One (2015)